Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Diabetes tablet that also protects heart and kidneys. | SGLT2 inhibitor for diabetes, heart failure and kidney disease. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | SGLT2 inhibitors | SGLT2 inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | Type 2 diabetes, Heart failure, Chronic kidney disease | Type 2 diabetes, Heart failure (all ejection fractions), Chronic kidney disease |
| How it works | Makes your kidneys flush out extra sugar and salt. | Pushes excess sugar and salt out through the urine. |
| Starts working | — | — |
| Half-life | About 12 hours | About 13 hours |
| Typical adult dose | 10 mg once a day (25 mg for extra glucose lowering). | 10 mg once a day. |
| Forms | Tablet, Combination tablets | Tablet, Combination tablets |
| Common side effects | Genital thrush, Urinary infections, Passing more urine, Thirst | Genital thrush, Urinary infections, Back pain |
| Serious side effects | Diabetic ketoacidosis even with near-normal sugar, Fournier's gangrene (very rare), Dehydration | Ketoacidosis, Dehydration, Fournier's gangrene (rare) |
| Don't take if | Type 1 diabetes (risk of ketoacidosis); Severe dehydration or ongoing vomiting; Recurrent genital or urinary infections | Type 1 diabetes (risk of ketoacidosis); Severe dehydration or ongoing vomiting; Recurrent genital or urinary infections |
| Alcohol | Best to limit. Heavy drinking raises the risk of ketoacidosis. | Best to limit. Heavy drinking raises the risk of ketoacidosis. |
| Pregnancy | Usually avoidedNot recommended. | Usually avoidedNot recommended. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | 2014 | 2012 |
| Brand names | United States: Jardiance, Synjardy (with metformin)United Kingdom: JardianceIndia: Jardiance, Gibtulio | United States: FarxigaUnited Kingdom: ForxigaIndia: Forxiga, Oxra, Udapa |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BK03 | A10BK01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker